These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8334938)

  • 1. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
    Chen K
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The screening model for early diagnosis of colorectal cancer in general population].
    Zheng S
    Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
    Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
    Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
    Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult-blood screening for colorectal carcinoma: the risks.
    Frank JW
    Am J Prev Med; 1985; 1(4):25-32. PubMed ID: 3870908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult-blood screening for colorectal carcinoma: the benefits.
    Frank JW
    Am J Prev Med; 1985; 1(3):3-9. PubMed ID: 3916713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for colorectal neoplasms. A review and recommendations].
    Kronborg O
    Ugeskr Laeger; 1993 Oct; 155(41):3272-7. PubMed ID: 8256320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer. Issues for primary care physicians.
    Realini JP
    Prim Care; 1988 Mar; 15(1):63-77. PubMed ID: 3043500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: new opportunities.
    Levin TR
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Summary of a new assessment strategy in positive occult blood tests in mass screening].
    Robra BP
    Leber Magen Darm; 1987 Apr; 17(2):113-24. PubMed ID: 3586827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.